uveal melanomas threaten visual loss enucleation death metastatic disease patients present symptoms failures detection diagnosis occur commonly treatments aimed avoiding enucleation include plaque proton beam stereotactic radiotherapy local resection transpupillary thermotherapy increasingly different modalities used combination ocular outcomes related tumour size location spread cell type metastatic disease occurs patients related factors tumour dimensions ciliary body involvement cell type extravascular matrix patterns cytogenetics abnormalities related chromosomes NUMBER NUMBER NUMBER strongly related tumour behaviour time enabling survival probability estimated high degree reliability individual patient enables individuals targeted screening providing reassurance minimal chance developing metastatic disease targeting allow selection patients adjuvant systemic therapy suitable treatment available facilitate evaluation treatment increasing statistical power randomized prospective study high mortality patients monosomy NUMBER melanoma suggests patients ocular treatment palliative cytogenetic studies suggest melanomas develop metastatic potential impressions confirmed studies patients main priority treatment conserve vision references NUMBER trans scleral trans retinal high risk